Research Topics
| Chris DyeSummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Health and urban livingChristopher Dye
World Health Organization, 1211 Geneva 27, Switzerland
Science 319:766-9. 2008..Subject to better evidence, I suggest that the main obstacles to improving urban health are not technical or even financial, but rather are related to governance and the organization of civil society...
Highly active antiretroviral treatment for the prevention of HIV transmissionReuben Granich
Department of HIV AIDS, World Health Organization, Geneva, Switzerland
J Int AIDS Soc 13:1. 2010..To explore HAART as a prevention strategy, we recommend further discussions to explore human rights and ethical considerations, clarify research priorities and review feasibility and acceptability issues...
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidenceCatherine R Stevenson
Medical Research Council Epidemiology Unit, Cambridge, UK
BMC Public Health 7:234. 2007..Diabetes increases the risk of TB. Our aim was to assess the potential impact of diabetes as a risk factor for incident pulmonary tuberculosis, using India as an example...
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalenceChristine S M Currie
School of Mathematics, University of Southampton, Southampton, SO17 1BJ, UK
BMC Public Health 5:130. 2005..However, published cost and cost-effectiveness studies are limited...
Alcohol use as a risk factor for tuberculosis - a systematic reviewKnut Lonnroth
Stop TB Department, World Health Organization, Geneva, Switzerland
BMC Public Health 8:289. 2008..Nor has the strength of the association been established. The objective of this study was to systematically review the available evidence on the association between alcohol use and the risk of tuberculosis...
Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007Ryuichi Komatsu
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Chemin Blandonnet 8, 1214 Vernier, Geneva, Switzerland
BMC Infect Dis 10:109. 2010..This paper presents and discusses a methodology for estimating the lives saved through selected service deliveries reported to the Global Fund...
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globallyChristopher Dye
Stop TB Department, World Health Organization, Geneva, Switzerland
JAMA 293:2767-75. 2005....
Nutrition, diabetes and tuberculosis in the epidemiological transitionChristopher Dye
HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
PLoS ONE 6:e21161. 2011..Interactions between diabetes and BMI could help or hinder TB control in growing, aging, urbanizing populations...
Targets for global tuberculosis controlC Dye
Stop TB Department, World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 10:460-2. 2006..This paper reviews the history of target setting for TB control and lays out the complete set of indicators and targets that will guide TB control through to 2015, the target year for all MDGs...
Did we reach the 2005 targets for tuberculosis control?Christopher Dye
Stop TB Department, World Health Organization, Geneva, Switzerland
Bull World Health Organ 85:364-9. 2007....
Eliminating human tuberculosis in the twenty-first centuryChristopher Dye
HIV AIDS, Tuberculosis and Malaria, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
J R Soc Interface 5:653-62. 2008..Our results should be a stimulus to those who develop, manufacture and implement new technology for TB control, and to their financial donors...
Global epidemiology of tuberculosisChristopher Dye
HIV/AIDS, Tuberculosis and Malaria, WHO, CH-1211 Geneva 27, Switzerland
Lancet 367:938-40. 2006
The decline of tuberculosis epidemics under chemotherapy: a case study in MoroccoC Dye
Stop TB Department, World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 11:1225-31. 2007..At the current pace of epidemic decline, there will be more than 10,000 new cases in 2050, the target year for global elimination...
Measuring tuberculosis burden, trends, and the impact of control programmesC Dye
HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
Lancet Infect Dis 8:233-43. 2008..By 2015, every country should be able to assess progress in tuberculosis control by estimating the time trend in incidence, and the magnitude of reductions in either prevalence or deaths...
Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosisChristopher Dye
World Health Organization, Geneva 27, Switzerland
Nat Rev Microbiol 7:81-7. 2009..Recent data suggest that national TB control programmes that use existing drugs efficiently can postpone and even reverse epidemics of multidrug-resistant TB, although the effect of such programmes on XDR strains remains largely unknown...
Trends in tuberculosis incidence and their determinants in 134 countriesC Dye
Stop TB Department, World Health Organization, Geneva, Switzerland
Bull World Health Organ 87:683-91. 2009..To determine whether differences in national trends in tuberculosis incidence are attributable to the variable success of control programmes or to biological, social and economic factors...
Slow elimination of multidrug-resistant tuberculosisChristopher Dye
Office of HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, CH1211 Geneva 27, Switzerland
Sci Transl Med 1:3ra8. 2009..This result applies even to countries such as Estonia and Latvia, which have exceptionally high prevalence rates of multidrug-resistant tuberculosis...
The population dynamics and control of tuberculosisChristopher Dye
World Health Organization, CH1211 Geneva 27, Switzerland
Science 328:856-61. 2010..Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied...
Will tuberculosis become resistant to all antibiotics?C Dye
Communicable Diseases, World Health Organization, Geneva, Switzerland
Proc Biol Sci 268:45-52. 2001..To substantiate this result, further measurements are needed of the relative fitness of drug-resistant strains...
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosisChristopher Dye
Communicable Diseases, World Health Organization, CH 1211 Geneva 27, Switzerland
Science 295:2042-6. 2002....
Worldwide incidence of multidrug-resistant tuberculosisChristopher Dye
Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
J Infect Dis 185:1197-202. 2002..2% of all new TB cases. The analysis provides the first comprehensive set of estimates of the MDR TB burden by country and globally...
What is the limit to case detection under the DOTS strategy for tuberculosis control?Christopher Dye
Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
Tuberculosis (Edinb) 83:35-43. 2003....
Epidemiology. Modeling the SARS epidemicChris Dye
Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
Science 300:1884-5. 2003
Planning to improve global health: the next decade of tuberculosis controlDermot Maher
Stop TB Department, WHO, Geneva, Switzerland
Bull World Health Organ 85:341-7. 2007..This approach to planning for global tuberculosis control is a valuable example of developing plans to improve global health that has relevance for other health issues...
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countriesM A Espinal
World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
JAMA 283:2537-45. 2000....
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring ProjectC Dye
Communicable Diseases Prevention and Control, World Health Organization, Geneva, Switzerland
JAMA 282:677-86. 1999..To estimate the risk and prevalence of Mycobacterium tuberculosis (MTB) infection and tuberculosis (TB) incidence, prevalence, and mortality, including disease attributable to human immunodeficiency virus (HIV), for 212 countries in 1997...
Criteria for the control of drug-resistant tuberculosisC Dye
Communicable Disease Control, Prevention and Eradication, World Health Organization, CH 1211 Geneva 27, Switzerland
Proc Natl Acad Sci U S A 97:8180-5. 2000..We discuss the implications of these results for World Health Organization policy on the management of antibiotic resistance...
Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring ProjectM C Raviglione
Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
Lancet 350:624-9. 1997....
The design effect and cluster samples: optimising tuberculosis prevalence surveysB Williams
World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 12:1110-5. 2008..We illustrate the results using data from a recent survey in Cambodia in which TB was diagnosed using sputum smears, cultures and X-rays...
Tuberculosis prevalence surveys: rationale and costP Glaziou
World Health Organization, Regional Office for the Western Pacific, Manila, Philippines
Int J Tuberc Lung Dis 12:1003-8. 2008..The cost of a prevalence survey is typically US$ 4-15 per person surveyed, and up to US$ 25 per person with radiographic screening. A survey of 50,000 people, of limited precision, would typically cost US$ 200,000-1,250,000...
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceM A Espinal
Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
N Engl J Med 344:1294-303. 2001..Data on global trends in resistance to antituberculosis drugs are lacking...
The impact of HIV/AIDS on the control of tuberculosis in IndiaB G Williams
World Health Organization, 20 Avenue Appia, Geneva 1212, Switzerland
Proc Natl Acad Sci U S A 102:9619-24. 2005....
Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapyC Dye
Global Tuberculosis Programme, WHO, Geneva, Switzerland
Lancet 352:1886-91. 1998..WHO advocates the use of directly observed treatment with a short-course drug regimen as part of the DOTS strategy, but the potential effect of this strategy worldwide has not been investigated...
Tuberculosis 2000-2010: control, but not eliminationC Dye
Communicable Diseases Control, Prevention and Eradication, World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 4:S146-52. 2000..Even if morbidity and mortality are significantly reduced before 2010, tuberculosis infection will persist for much longer, acting as a sensitive indicator of public health, and as a marker of the quality of health services...
Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance?D Maher
Stop TB Department, World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 9:123-7. 2005....
The measurement and estimation of tuberculosis mortalityE L Korenromp
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland
Int J Tuberc Lung Dis 13:283-303. 2009....
Low access to a highly effective therapy: a challenge for international tuberculosis controlChristopher Dye
Communicable Diseases, World Health Organization, Geneva, Switzerland
Bull World Health Organ 80:437-44. 2002..The challenge now is to show that DOTS expansion in the major endemic countries can significantly accelerate case finding while maintaining high cure rates...
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold minersElizabeth L Corbett
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
Am J Respir Crit Care Med 170:673-9. 2004..The difference in mean duration of smear positivity was particularly marked and, if generalizable, will have major implications for TB control prospects in high HIV prevalence areas...
Breaking a law: tuberculosis disobeys Styblo's ruleChristopher Dye
Bull World Health Organ 86:4. 2008
The science of social diseasesChristopher Dye
Science 307:181. 2005
Estimates of world-wide distribution of child deaths from acute respiratory infectionsBrian G Williams
World Health Organization, 20 Avenue Appia, Geneva 27, CH 1211, Switzerland
Lancet Infect Dis 2:25-32. 2002..This analysis suggests that throughout the world 1.9 million (95% CI 1.6-2.2 million) children died from ARI in 2000, 70% of them in Africa and southeast Asia...
Financing tuberculosis control: the role of a global financial monitoring systemKatherine Floyd
Stop TB Department, World Health Organization, Geneva, Switzerland
Bull World Health Organ 85:334-40. 2007..We also analyse the strengths and limitations of the system and its relevance to other health-care programmes...
Reducing the global burden of tuberculosis: the contribution of improved diagnosticsEmmett Keeler
RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407-2138, USA
Nature 444:49-57. 2006
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populationsBrian G Williams
Stop TB Department, World Health Organization, Geneva 1211 CH 1211, Switzerland
J Infect Dis 194:1450-8. 2006....
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical reviewEline L Korenromp
Communicable Diseases, Stop TB Department, World Health Organization, Geneva, Switzerland
Clin Infect Dis 37:101-12. 2003..025). In countries where HIV infection is endemic, TB recurrence may be reduced by administration of rifampin-based treatment for at least 6 months, in accordance with World Health Organization recommendations...
Can DOTS control multidrug-resistant tuberculosis?Marcos A Espinal
Stop TB Partnership, World Health Organization, CH-1211 Geneva, Switzerland
Lancet 365:1206-9. 2005
Monitoring global health: WHO has mandate and expertiseChristopher Dye
BMJ 330:195. 2005
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsyEline L Korenromp
Malaria Control Department of WHO, Geneva, Switzerland
Lancet Infect Dis 3:349-58. 2003....
Tuberculosis epidemics driven by HIV: is prevention better than cure?Christine S M Currie
Faculty of Mathematical Studies, University of Southampton, Southampton, UK
AIDS 17:2501-8. 2003..To ensure effective control of TB in the longer term, methods of TB prevention should be carried out in addition to, but not as a substitute for, treating active cases...
TuberculosisThomas R Frieden
New York City Department of Health and Mental Hygiene, New York, NY 10013, USA
Lancet 362:887-99. 2003..Until tuberculosis is controlled worldwide, it will continue to be a major killer in less-developed countries and a constant threat in most of the more-developed countries...
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDSBrian G Williams
Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
Science 301:1535-7. 2003..However, ARV drugs could enhance the treatment of TB, and TB programs provide an important entry point for the treatment of HIV/AIDS...
Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 yearsEline L Korenromp
World Health Organization, Roll Back Malaria Monitoring and Evaluation, Geneva, Switzerland
Trop Med Int Health 8:693-703. 2003..To investigate the strengths and weaknesses of the indicators 'proportion of households possessing mosquito net(s)' and 'proportion of children under 5 years of age who slept under a net the preceding night' for monitoring malaria control...
Tuberculosis control in the era of HIVPaul Nunn
Stop TB Department, World Health Organization, Via Appia 27, CH 1211, Geneva 12, Switzerland
Nat Rev Immunol 5:819-26. 2005..As a consequence, global TB control policies have had to be revised and control of TB now demands increased investment. This paper assesses what is being done to address the issue and what remains to be done...
Cost effectiveness analysis of strategies for tuberculosis control in developing countriesRob Baltussen
Institute for Medical Technology Assessment iMTA, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, Netherlands
BMJ 331:1364. 2005..To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals...
The development and impact of tuberculosis vaccinesDouglas Young
Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom
Cell 124:683-7. 2006..But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control...
Public health. A National Tuberculosis ArchiveDamian Gessler
National Center for Genome Resources, Santa Fe, NM 87505, USA
Science 311:1245-6. 2006
The growing burden of tuberculosis: global trends and interactions with the HIV epidemicElizabeth L Corbett
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England, UK
Arch Intern Med 163:1009-21. 2003..The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency...
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaborationAlasdair Reid
Stop TB Department, WHO, Geneva, Switzerland
Lancet Infect Dis 6:483-95. 2006....
Global incidence of multidrug-resistant tuberculosisMatteo Zignol
Stop TB Department, World Health Organization, Geneva 1211, Switzerland
J Infect Dis 194:479-85. 2006....
The potential impact of male circumcision on HIV in Sub-Saharan AfricaBrian G Williams
World Health Organization, Stop TB Department, Geneva, Switzerland
PLoS Med 3:e262. 2006..We explore the implications of this finding for the promotion of MC as a public health intervention to control HIV in sub-Saharan Africa...
India's leading role in tuberculosis epidemiology & controlChristopher Dye
Indian J Med Res 123:481-4. 2006
A booster for tuberculosis vaccinesChristopher Dye
JAMA 291:2127-8. 2004
Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmissionOrin Courtenay
Ecology and Epidemiology Group, Department of Biological Sciences, University of Warwick, Coventry, United Kingdom
J Infect Dis 186:1314-20. 2002..Mathematical modeling suggests that culling programs fail because of high incidence of infection and infectiousness, the insensitivity of the diagnostic test to detect infectious dogs, and time delays between diagnosis and culling...
Diabetes and the risk of tuberculosis: a neglected threat to public health?Catherine R Stevenson
Medical Research Council Epidemiology Unit, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK
Chronic Illn 3:228-45. 2007..However, this is rarely highlighted in current research or control priorities. This paper aims to evaluate the evidence for an association between these two diseases...
Modeling the impact of immigration on the epidemiology of tuberculosisZhong Wei Jia
School of Information Engineering, Beijing University of Posts and Telecommunications, 10 Xitucheng Road, Beijing 100876, PR China
Theor Popul Biol 73:437-48. 2008..This finding is also supported by numerical simulations with the extended model. Our study suggests that immigrants have a considerable influence on the overall transmission dynamics behavior of tuberculosis...
